New Products Development

anaptixi

We develop new products committed to quality and safety

The main activity of the Research and Development Department is the development of European levelcompetitive generic pharmaceuticals in order to increase the product portfolio of the company. The development of the new medicines is done with commitment to the quality and safety and following the GMPand GLP standards.

 

The department’s laboratories and the production areas of pilot and test products cover more than 800 m² and are equipped with modern analytical instruments and machinery and are staffed by qualified and experienced scientists of all relevant disciplines. Multiple collaborations have been established with leading laboratories of Greek and foreign universities and Research Institutes for the development of new pharmaceutical formulations.